Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Am J Gastroenterol. 2017 Dec 12;113(2):235–242. doi: 10.1038/ajg.2017.443

Table 1.

Characteristics of the 529 patients with cirrhosis enrolled in this study

Characteristics n=529
Age, years 58 (50–63)
Female 220 (42%)
Race
  Non-Hispanic White 307 (58%)
  Black 17 (3%)
  Hispanic White 133 (25%)
  Asian/Pacific Islander 24 (5%)
  Other 48 (9%)
Body mass index, kg/m2 28 (25–33)
Etiology of liver disease
  Chronic hepatitis C 203 (38%)
  Alcohol 122 (23%)
  Non-alcoholic steatohepatitis 72 (14%)
  Autoimmune/cholestatic 77 (15%)
  Other 55 (10%)
Hypertension 204 (39%)
Diabetes 145 (27%)
MELDNa 18 (15–23)
  Total bilirubin, mg/dl 2.6 (1.7–4.2)
  Creatinine, mg/dla 0.91 (0.72–1.20)
  International normalized ratio for prothrombin time 1.4 (1.3–1.6)
  Sodium, mEq/l 136 (133–139)
Albumin, g/dl 3.0 (2.6–3.4)
Dialysis 23 (4%)
Ascites
  Mild/moderate 143 (27%)
  Refractory 35 (7%)
Hepatic encephalopathy 99 (19%)
Dialysis 23 (4%)
Child Pugh Class
  A 78 (15%)
  B 335 (64%)
  C 108 (21%)
Follow-up time, months 11 (4–21)
Outcome
  Waiting 224 (42%)
  Death/delisted for being too sick for transplant 102 (19%)
  Deceased donor liver transplant 131 (25%)
  Other 72 (14%)

MELDNa, Model for End-Stage Liver Disease.

Values are median (interquartile range) or n (%).

a

Among those who were not on dialysis.